Disorders of adhesions or adhesion-related disorder: monolithic entities or part of something bigger--CAPPS?

The purpose of this article is to review progress in the field of abdominopelvic adhesions and the validity of its two underlying assumptions: (1) The formation of adhesions results in infertility, bowel obstruction, or other complications. Reducing or avoiding adhesions will curb these sequelae. (2) “Adhesions” is a monolithic entity to be tackled without regard to any other condition. Evidence is discussed to validate the first assumption. We reviewed progress in the field by examining hospital data. We found a growing trend in the number and cost of discharges for just two adhesion-related diagnoses, and the low usage of adhesion barriers appears in at most 5% of appropriate procedures. Data from an Internet-based survey suggested that the problem may be partly due to ignorance among patients and physicians about adhesions and their prevention. Two other surveys of patients visiting the adhesions.org Web site defined more fully adhesion-related disorder (ARD). The first survey (N = 466) described a patient with chronic pain, gastrointestinal disturbances, an average of nine bowel obstructions, and an inability to work or maintain family or social relationships. The second survey (687 U.S. women) found a high (co-) prevalence of abdominal or pelvic adhesions (85%), chronic abdominal or pelvic pain (69%), irritable bowel syndrome (55%), recurrent bowel obstruction (44%), endometriosis (40%), and interstitial cystitis (29%). This pattern suggests that although “adhesions” may start out as a monolithic entity, an adhesions patient may develop related conditions (ARD) until they merge into an independent entity where they are practically indistinguishable from patients with multiple symptoms originating from other abdominopelvic conditions such as pelvic or bladder pain. Rather than use terms that constrain the required multidisciplinary, biopsychosocial approach to these patients by the paradigms of the specialty related to the patient's initial symptom set, the term complex abdominopelvic and pain syndrome (CAPPS) is proposed. It is essential to understand not only the pathogenesis of the “initiating” conditions but also how they progress to CAPPS. In our ARD sample, not only was the frequency of women with hysterectomies (56%) higher than expected (21 to 33%), but also the rates of the “initiating” conditions was 40 to 400% higher in patients with hysterectomies than in those without. This may represent increased surgical trauma or the loss of protection against oxidative stress. Related was the higher frequency of ARD patients reporting hemochromatosis (HC; 5%) than expected (~0.5%) and the higher rates (20 to 700%) of initiating conditions in patients with HC than in those without HC. Together with findings related to the toxicity of Intergel, these findings raise the possibility that heterozygotes for genes regulating oxidative stress are at greater risk of developing surgical complications as well as more severe and progressive conditions such as CAPPS.

Adhesions - adhesion-related disorder - complex abdominopelvic and pain syndrome - chronic pelvic pain - hysterectomy - iron overload - hemochromatosis

- 1 Wiseman D M. Adhesion prevention: past the future . In: diZerega G, DeCherney A, Diamond M, et al. Peritoneal Surgery. New York, NY; Springer-Verlag 2000: 401-418 - 2 Wiseman D M, Trout J R, Franklin R R, Diamond M P. Metaanalysis of the safety and efficacy of an adhesion barrier (Interceed TC7) in laparotomy. J Reprod Med. 1999; 44 325-331 - 3 Beck D E, Cohen Z, Fleshman J W, Kaufman H S, van Goor H, Wolff B G. A prospective, randomized, multicenter, controlled study of the safety of Seprafilm adhesion barrier in abdominopelvic surgery of the intestine. Dis Colon Rectum. 2003; 46 1310-1319 - 4 Diamond M P. Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): a blinded, prospective, randomized, multicenter clinical study. Seprafilm Adhesion Study Group. Fertil Steril. 1996; 66 904-910 - 5 Haney A F, Hesla J, Hurst B S et al.. Expanded polytetrafluoroethylene (Gore-Tex Surgical Membrane) is superior to oxidized regenerated cellulose (Interceed TC7) in preventing adhesions. Fertil Steril. 1995; 63 1021-1026 - 6 Diamond MP and the Sepracoat Adhesion Study Group . Reduction of de novo postsurgical adhesions by intraoperative precoating with Sepracoat (HAL-C) solution: a prospective, randomized, blinded, placebo-controlled multicenter study. The Sepracoat Adhesion Study Group. Fertil Steril. 1998; 69 1067-1074 - 7 Johns D B, Keyport G M, Hoehler F, diZerega G S. Reduction of postsurgical adhesions with Intergel adhesion prevention solution: a multicenter study of safety and efficacy after conservative gynecologic surgery. Fertil Steril. 2001; 76 595-604 - 8 Wiseman D M. Possible Intergel reaction syndrome (pIRS). Ann Surg. 2006; 244 630-632 - 9 Holmdahl L. Mechanisms of adhesion development and effects on wound healing. Eur J Surg Suppl. 1997; 579 7-9 - 10 Practice Committee of the American Society for Reproductive Medicine . Pathogenesis, consequences, and control of peritoneal adhesions in gynecologic surgery. Fertil Steril. 2007; 88 21-26 - 11 Liakakos T, Thomakos N, Fine P M, Dervenis C, Young R L. Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Recent advances in prevention and management. Dig Surg. 2001; 18 260-273 - 12 Lower A M, Hawthorn R J, Clark D et al.. Adhesion-related readmissions following gynaecological laparoscopy or laparotomy in Scotland: an epidemiological study of 24 046 patients. Hum Reprod. 2004; 19 1877-1885 - 13 Lower A M, Hawthorn R J, Ellis H, O'Brien F, Buchan S, Crowe A M. The impact of adhesions on hospital readmissions over ten years after 8849 open gynaecological operations: an assessment from the Surgical and Clinical Adhesions Research Study. BJOG. 2000; 107 855-862 - 14 Ivarsson M L, Holmdahl L, Franzen G, Risberg B. Cost of bowel obstruction resulting from adhesions. Eur J Surg. 1997; 163 679-684 - 15 Jeekel H. Cost implications of adhesions as highlighted in a European study. Eur J Surg Suppl. 1997; 579 43-45 - 16 Ray N F, Denton W G, Thamer M, Henderson S C, Perry S. Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg. 1998; 186 1-9 - 17 Farquhar C, Vandekerckhove P, Watson A, Vail A, Wiseman D. Barrier agents for preventing adhesions after surgery for subfertility. Cochrane Database Syst Rev. 2000; CD000475 - 18 Wiseman D M. Correlations between animal and human models of adhesions . Diamond MP, DeCherney AH Infertility and Reproductive, Medical Clinics of North America. 2003: 391-401 - 19 Attard J A, MacLean A R. Adhesive small bowel obstruction: epidemiology, biology and prevention. Can J Surg. 2007; 50 291-300 - 20 Al-Jaroudi D, Tulandi T. Adhesion prevention in gynecologic surgery. Obstet Gynecol Surv. 2004; 59 360-367 - 21 Diamond M P, Freeman M L. Clinical implications of postsurgical adhesions. Hum Reprod Update. 2001; 7 567-576 - 22 Food and Drug Administration .Guidance for resorbable adhesion barrier devices for use in abdominal and/or pelvic surgery; Guidance for Industry. 2002. http://Available at: www.fda.gov/cdrh/ode/guidance/1356.pdf Accessed November 23, 2006 - 23 Ellis H, Moran B J, Thompson J N et al.. Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet. 1999; 353 1476-1480 - 24 Fushiki H, Ikoma T, Kobayashi H, Yoshimoto H. Efficacy of Seprafilm as an adhesion barrier in cesarean sections. Obstet Gynecol Treatment. 2005; 91 557-561 - 25 Inoue M, Uchida K, Miki C, Kusunoki M. Efficacy of Seprafilm for reducing reoperative risk in pediatric surgical patients undergoing abdominal surgery. J Pediatr Surg. 2005; 40 1301-1306 - 26 Salum M, Wexner S D, Nogueras J J et al.. Does sodium hyaluronate- and carboxymethylcellulose-based bioresorbable membrane (Seprafilm) decrease operative time for loop ileostomy closure?. Tech Coloproctol. 2006; 10 187-190 - 27 American Fertility Society . The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, mullerian anomalies and intrauterine adhesions. Fertil Steril. 1988; 49 944-955 - 28 Bronson R A, Wallach E E. Lysis of periadnexal adhesions for correction of infertility. Fertil Steril. 1977; 28 613-619 - 29 Marana R, Rizzi M, Muzii L, Catalano G F, Caruana P, Mancuso S. Correlation between the American Fertility Society classifications of adnexal adhesions and distal tubal occlusion, salpingoscopy, and reproductive outcome in tubal surgery. Fertil Steril. 1995; 64 924-929 - 30 Marana R, Catalano G F, Muzii L, Caruana P, Margutti F, Mancuso S. The prognostic role of salpingoscopy in laparoscopic tubal surgery. Hum Reprod. 1999; 14 2991-2995 - 31 Tulandi T, Collins J A, Burrows E et al.. Treatment-dependent and treatment-independent pregnancy among women with periadnexal adhesions. Am J Obstet Gynecol. 1990; 162 354-357 - 32 Sawada T, Nishizawa H, Nishio E, Kadowaki M. Postoperative adhesion prevention with an oxidized regenerated cellulose adhesion barrier in infertile women. J Reprod Med. 2000; 45 387-389 - 33 Ellis H. The clinical significance of adhesions: focus on intestinal obstruction. Eur J Surg Suppl. 1997; 579 5-9 - 34 Wilson M S, Ellis H, Menzies D, Moran B J, Parker M C, Thompson J N. A review of the management of small bowel obstruction. Members of the Surgical and Clinical Adhesions Research Study (SCAR). Ann R Coll Surg Engl. 1999; 81 320-328 - 35 Nagle A, Ujiki M, Denham W, Murayama K. Laparoscopic adhesiolysis for small bowel obstruction. Am J Surg. 2004; 187 464-470 - 36 Fazio V W, Cohen Z, Fleshman J W et al.. Reduction in adhesive small-bowel obstruction by Seprafilm adhesion barrier after intestinal resection. Dis Colon Rectum. 2006; 49 1-11 - 37 Mohri Y, Uchida K, Araki T et al.. Hyaluronic acid-carboxycellulose membrane (Seprafilm) reduces early postoperative small bowel obstruction in gastrointestinal surgery. Am Surg. 2005; 71 861-863 - 38 Kudo F A, Nishibe T, Miyazaki K, Murashita T, Nishibe M, Yasuda K. Use of bioresorbable membrane to prevent postoperative small bowel obstruction in transabdominal aortic aneurysm surgery. Surg Today. 2004; 34 648-651 - 39 Zeng Q, Yu Z, You J, Zhang Q. Efficacy and safety of Seprafilm for preventing postoperative abdominal adhesion: systematic review and meta-analysis. World J Surg. 2007; 31 2125-2131 - 40 Alexander-Williams J. Do adhesions cause pain?. Br Med J (Clin Res Ed). 1987; 294 659-660 - 41 Hammoud A, Gago L A, Diamond M P. Adhesions in patients with chronic pelvic pain: a role for adhesiolysis?. Fertil Steril. 2004; 82 1483-1491 - 42 Herrick S E, Mutsaers S E, Ozua P et al.. Human peritoneal adhesions are highly cellular, innervated, and vascularized. J Pathol. 2000; 192 67-72 - 43 Demco L. Pain mapping of adhesions. J Am Assoc Gynecol Laparosc. 2004; 11 181-183 - 44 Howard F M. The role of laparoscopy in chronic pelvic pain: promise and pitfalls. Obstet Gynecol Surv. 1993; 48 357-387 - 45 Freys S M, Fuchs K H, Heimbucher J, Thiede A. Laparoscopic adhesiolysis. Surg Endosc. 1994; 8 1202-1207 - 46 Steege J F, Stout A L. Resolution of chronic pelvic pain after laparoscopic lysis of adhesions. Am J Obstet Gynecol. 1991; 165 278-281 - 47 Daniell J F. Laparoscopic enterolysis for chronic abdominal pain. J Gynecol Surg. 1989; 5 61-66 - 48 Peters A A, Trimbos-Kemper G C, Admiraal C, Trimbos J B, Hermans J. A randomized clinical trial on the benefit of adhesiolysis in patients with intraperitoneal adhesions and chronic pelvic pain. Br J Obstet Gynaecol. 1992; 99 59-62 - 49 Baker P N, Symonds E M. The resolution of chronic pelvic pain after normal laparoscopy findings. Am J Obstet Gynecol. 1992; 166 835-836 - 50 Swank D J, Swank-Bordewijk S C, Hop W C et al.. Laparoscopic adhesiolysis in patients with chronic abdominal pain: a blinded randomised controlled multi-centre trial. Lancet. 2003; 361 1247-1251 - 51 Moseley J B, O'Malley K, Petersen N J et al.. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2002; 347 81-88 - 52 Jarrell J, Mohindra R, Ross S, Taenzer P, Brant R. Laparoscopy and reported pain among patients with endometriosis. J Obstet Gynaecol Can. 2005; 27 477-485 - 53 Wiseman D M, Trout J R, Diamond M P. The rates of adhesion development and the effects of crystalloid solutions on adhesion development in pelvic surgery. Fertil Steril. 1998; 70(4) 702-711 - 54 Khaitan L, Scholz S, Houston H L, Richards W O. Results after laparoscopic lysis of adhesions and placement of Seprafilm for intractable abdominal pain. Surg Endosc. 2003; 17 247-253 - 55 Menzies D, Ellis H. Intestinal obstruction from adhesions–how big is the problem?. Ann R Coll Surg Engl. 1990; 72 60-63 - 56 Wiseman D M. Polymers for the prevention of surgical adhesions . In: Domb AJ Polymeric Site-Specific Pharmacotherapy. Chichester, England; John Wiley 1994: 369-421 - 57 Wiseman D. Information and consent regarding adhesions: an internet survey. J Minim Invasive Gynecol. 2006; 13 S73 - 58 Ellis H. Medicolegal consequences of adhesions. Hosp Med. 2004; 65 348-350 - 59 Courtney M J. Information about surgery: what does the public want to know?. Aust N Z J Surg. 2001; 71 24-26 - 60 Lloyd A, Hayes P, Bell P R, Naylor A R. The role of risk and benefit perception in informed consent for surgery. Med Decis Making. 2001; 21 141-149 - 61 Wiseman D. Severe adhesion related disorder (ARD); pattern of bowel dysfunction and obstruction, social and physician issues: an Internet survey. J Minim Invasive Gynecol. 2006; 13 S65-S66 - 62 Kotarinos R K. Pelvic floor physical therapy in urogynecologic disorders. Curr Womens Health Rep. 2003; 3 334-339 - 63 Vizzard M A. Alterations in spinal cord Fos protein expression induced by bladder stimulation following cystitis. Am J Physiol Regul Integr Comp Physiol. 2000; 278 R1027-R1039 - 64 LaBerge J, Malley S E, Zvarova K, Vizzard M A. Expression of corticotropin-releasing factor and CRF receptors in micturition pathways after cyclophosphamide-induced cystitis. Am J Physiol Regul Integr Comp Physiol. 2006; 291 R692-R703 - 65 Qiao L Y, Vizzard M A. Cystitis-induced upregulation of tyrosine kinase (TrkA, TrkB) receptor expression and phosphorylation in rat micturition pathways. J Comp Neurol. 2002; 454 200-211 - 66 Melzack R. Phantom limb pain. Patol Fiziol Eksp Ter. 1992; 4 52-54 - 67 Brena S F, Sammons E E. Phantom urinary bladder pain–case report. Pain. 1979; 7 197-201 - 68 Biley F C. Phantom bladder sensations: a new concern for stoma care workers. Br J Nurs. 2001; 10 1290-1296 - 69 Rogers R M. Basic pelvic neuroanatomy . In: Steege JF, Metzger DA, Levy BS Chronic Pelvic Pain. Philadelphia, PA; W.B. Saunders 1998: 31-58 - 70 Wesselmann U, Burnett A L, Heinberg L J. The urogenital and rectal pain syndromes. Pain. 1997; 73 269-294 - 71 Pezzone M A, Liang R, Fraser M O. A model of neural cross-talk and irritation in the pelvis: implications for the overlap of chronic pelvic pain disorders. Gastroenterology. 2005; 128 1953-1964 - 72 Giamberardino M A, Berkley K J, Affaitati G et al.. Influence of endometriosis on pain behaviors and muscle hyperalgesia induced by a ureteral calculosis in female rats. Pain. 2002; 95 247-257 - 73 Bielefeldt K, Lamb K, Gebhart G F. Convergence of sensory pathways in the development of somatic and visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol. 2006; 291 G658-G665 - 74 Ustinova E E, Fraser M O, Pezzone M A. Colonic irritation in the rat sensitizes urinary bladder afferents to mechanical and chemical stimuli: an afferent origin of pelvic organ cross-sensitization. Am J Physiol Renal Physiol. 2006; 290 F1478-F1487 - 75 Winnard K P, Dmitrieva N, Berkley K J. Cross-organ interactions between reproductive, gastrointestinal, and urinary tracts: modulation by estrous stage and involvement of the hypogastric nerve. Am J Physiol Regul Integr Comp Physiol. 2006; 291 R1592-R1601 - 76 Gomel V. Chronic pelvic pain: a challenge. J Minim Invasive Gynecol. 2007; 14 521-526 - 77 Zondervan K T, Yudkin P L, Vessey M P et al.. Chronic pelvic pain in the community–symptoms, investigations, and diagnoses. Am J Obstet Gynecol. 2001; 184 1149-1155 - 78 Stanford E J, Koziol J, Feng A. The prevalence of interstitial cystitis, endometriosis, adhesions, and vulvar pain in women with chronic pelvic pain. J Minim Invasive Gynecol. 2005; 12 43-49 - 79 Engel G L. The need for a new medical model: a challenge for biomedicine. Science. 1977; 196 129-136 - 80 Wesselmann U, Czakanski P P. Pelvic pain: a chronic visceral pain syndrome. Curr Pain Headache Rep. 2001; 5 13-19 - 81 Peters A A, Van den Tillaart S A. The difficult patient in gastroenterology: chronic pelvic pain, adhesions, and sub occlusive episodes. Best Pract Res Clin Gastroenterol. 2007; 21 445-463 - 82 Stanford E J, Dell J R, Parsons C L. The emerging presence of interstitial cystitis in gynecologic patients with chronic pelvic pain. Urology. 2007; 69 53-59 - 83 Levey K A. Chronic pelvic pain. J Minim Invasive Gynecol. 2004; 11 546 - 84 Peters A A, van Dorst E, Jellis B, van Zuuren E, Hermans J, Trimbos J B. A randomized clinical trial to compare two different approaches in women with chronic pelvic pain. Obstet Gynecol. 1991; 77 740-744 - 85 Reiter R C. Evidence-based management of chronic pelvic pain. Clin Obstet Gynecol. 1998; 41 422-435 - 86 Steege J F, Stout A L, Somkuti S G. Chronic pelvic pain in women: toward an integrative model. Obstet Gynecol Surv. 1993; 48 95-110 - 87 Peters K M. Neuromodulation for the treatment of refractory interstitial cystitis. Rev Urol. 2002; 4(Suppl 1) S36-S43 - 88 Kapural L, Narouze S N, Janicki T I, Mekhail N. Spinal cord stimulation is an effective treatment for the chronic intractable visceral pelvic pain. Pain Med. 2006; 7 440-443 - 89 Bedaiwy M A, Falcone T, Mascha E J, Casper R F. Genetic polymorphism in the fibrinolytic system and endometriosis. Obstet Gynecol. 2006; 108 162-168 - 90 Wieser F, Tempfer C, Schneeberger C, van Trotsenburg M, Huber J, Wenzl R. Interleukin-1 receptor antagonist polymorphism in women with peritoneal adhesions. BJOG. 2002; 109 1298-1300 - 91 Duron J J, Silva N J, du Montcel S T et al.. Adhesive postoperative small bowel obstruction: incidence and risk factors of recurrence after surgical treatment: a multicenter prospective study. Ann Surg. 2006; 244 750-757 - 92 Fevang B T, Fevang J, Lie S A, Soreide O, Svanes K, Viste A. Long-term prognosis after operation for adhesive small bowel obstruction. Ann Surg. 2004; 240 193-201 - 93 Ingber M S, Peters K M, Killinger K A, Carrico D J, Ibrahim I A, Diokno A C. Dilemmas in diagnosing pelvic pain: multiple pelvic surgeries common in women with interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct. 2008; 19 341-345 - 94 Saed G M, Diamond M P. Molecular characterization of postoperative adhesions: the adhesion phenotype. J Am Assoc Gynecol Laparosc. 2004; 11 307-314 - 95 Kluivers K B, Mol B W, Bremer G L, Brolmann H A, Vierhout M E, Bongers M Y. Pelvic organ function in randomized patients undergoing laparoscopic or abdominal hysterectomy. J Minim Invasive Gynecol. 2007; 14 442-448 - 96 Stricker B, Blanco J, Fox H E. The gynecologic contribution to intestinal obstruction in females. J Am Coll Surg. 1994; 178 617-620 - 97 Ratcliff J B, Kapernick P, Brooks G G, Dunnihoo D R. Small bowel obstruction and previous gynecologic surgery. South Med J. 1983; 76 1349-1350 - 98 Monk B J, Berman M L, Montz F J. Adhesions after extensive gynecologic surgery: clinical significance, etiology, and prevention. Am J Obstet Gynecol. 1994; 170 1396-1403 - 99 Brett K M, Higgins J A. Hysterectomy prevalence by Hispanic ethnicity: evidence from a national survey. Am J Public Health. 2003; 93 307-312 - 100 Centers for Disease Control and Prevention . Hysterectomy prevalence and death rates for cervical cancer–United States, 1965–1988. MMWR Morb Mortal Wkly Rep. 1992; 41 17-20 - 101 Moirand R, Adams P C, Bicheler V, Brissot P, Deugnier Y. Clinical features of genetic hemochromatosis in women compared with men. Ann Intern Med. 1997; 127 105-110 - 102 Cade J E, Moreton J A, O'Hara B et al.. Diet and genetic factors associated with iron status in middle-aged women. Am J Clin Nutr. 2005; 82 813-820 - 103 Bureau I, Gueux E, Mazur A, Rock E, Roussel A M, Rayssiguier Y. Female rats are protected against oxidative stress during copper deficiency. J Am Coll Nutr. 2003; 22 239-246 - 104 Persky A M, Green P S, Stubley L et al.. Protective effect of estrogens against oxidative damage to heart and skeletal muscle in vivo and in vitro. Proc Soc Exp Biol Med. 2000; 223 59-66 - 105 Binda M M, Molinas C R, Koninckx P R. Reactive oxygen species and adhesion formation: clinical implications in adhesion prevention. Hum Reprod. 2003; 18 2503-2507 - 106 Alpay Z, Saed G M, Diamond M P. Female infertility and free radicals: potential role in adhesions and endometriosis. J Soc Gynecol Investig. 2006; 13 390-398 - 107 Gupta S, Agarwal A, Krajcir N, Alvarez J G. Role of oxidative stress in endometriosis. Reprod Biomed Online. 2006; 13 126-134 - 108 McDonnell S M, Preston B L, Jewell S A et al.. A survey of 2,851 patients with hemochromatosis: symptoms and response to treatment. Am J Med. 1999; 106 619-624 - 109 Burke W, Reyes M, Imperatore G. Hereditary haemochromatosis: a realistic approach to prevention of iron overload disease in the population. Best Pract Res Clin Haematol. 2002; 15 315-328 - 110 Tweed M J, Roland J M. Haemochromatosis as an endocrine cause of subfertility. BMJ. 1998; 316 915-916 - 111 Britton R S, Ramm G A, Olynyk J, Singh R, O'Neill R, Bacon B R. Pathophysiology of iron toxicity. Adv Exp Med Biol. 1994; 356 239-253 - 112 Goswami T, Rolfs A, Hediger M A. Iron transport: emerging roles in health and disease. Biochem Cell Biol. 2002; 80 679-689 - 113 Arumugam K, Yip Y C. De novo formation of adhesions in endometriosis: the role of iron and free radical reactions. Fertil Steril. 1995; 64 62-64 - 114 Van Langendonckt A, Casanas-Roux F, Donnez J. Iron overload in the peritoneal cavity of women with pelvic endometriosis. Fertil Steril. 2002; 78 712-718 - 115 Defrere S, Van Langendonckt A, Vaesen S et al.. Iron overload enhances epithelial cell proliferation in endometriotic lesions induced in a murine model. Hum Reprod. 2006; 21 2810-2816 - 116 Sullivan J L. Iron and the genetics of cardiovascular disease. Circulation. 1999; 100 1260-1263 - 117 Weinberg E D. Do some carriers of hemochromatosis gene mutations have higher than normal rates of disease and death?. Biometals. 2002; 15 347-350 - 118 Holmstrom P, Marmur J, Eggertsen G, Gafvels M, Stal P. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls. Gut. 2002; 51 723-730 - 119 Adams P C. Hemochromatosis. Clin Liver Dis. 2004; 8 735-753 vii - 120 Eisenbach C, Gehrke S G, Stremmel W. Iron, the HFE gene, and hepatitis C. Clin Liver Dis. 2004; 8 775-785 vii-viii - 121 Geier A, Reugels M, Weiskirchen R et al.. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C. Liver Int. 2004; 24 285-294 - 122 Andrews N C. Anemia of inflammation: the cytokine-hepcidin link. J Clin Invest. 2004; 113 1251-1253 - 123 Weiss G. Iron and anemia of chronic disease. Kidney Int Suppl. 1999; 69 S12-S17 - 124 Wiseman D. Possible Intergel reaction syndrome (pIRS): mechanisms and general consequences for patients undergoing surgery. J Minim Invasive Gynecol. 2006; 13 S67 - 125 Wiseman D M. Registries for anti-adhesion products?. Fertil Steril. 2006; 86 771 - 126 Lifecore Biomedical, Inc .Major Amendment to INTERGEL PMA P99015/A010 Appendix C: Summary of Safety and Effectiveness (Revised). June 2, 2000. http://Available at: www.fda.gov/ohrms/dockets/ac/01/briefing/3789b1_12_08_summary%20of%20S&E.pdf Accessed March 24, 2005 - 127 Courselaud B, Pigeon C, Inoue Y et al.. C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J Biol Chem. 2002; 277 41163-41170 - 128 Horbowyj R. INTERGEL Adhesion Prevention Solution. Clinical study of use during laparotomy for gynecologic interventions - FDA Clinical Perspective. September 6, 2001. http://Available at: www.fda.gov/ohrms/dockets/ac/01/briefing/3789b1_08.ppt Accessed March 28, 2005 - 129 Diatchenko L, Nackley A G, Slade G D et al.. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain. 2006; 125 216-224 - 130 Tegeder I, Costigan M, Griffin R S et al.. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med. 2006; 12 1269-1277 David M WisemanPh.D. PMB 238, International Adhesions Society, 6757 Arapaho Suite 711-238, Dallas, TX 75248 Email: [email protected]